- We are the Pharma Journal directory
Oral morphine sulphate supplied as Oramorph remains a first-line strong opioid when moderate to severe pain does not respond to weaker agents. The immediate release...
For acute pain, time matters. Patients with postoperative dental pain, primary dysmenorrhoea, tension-type headache or migraine want relief that begins quickly and remains reliable. Ibuprofen...
Huntington’s disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or...
Testosterone replacement therapy is widely requested, yet appropriate use depends on accurate diagnosis. True androgen deficiency is a clinical and biochemical syndrome. Symptoms must align...
Exposure and Response Prevention (ERP) sits at the centre of modern, evidence-based care for obsessive and anxiety-driven conditions. It is a structured behavioural method that...
It begins with a sachet. Small, honey-filled, and stamped with branding like “Royal Honey VIP” or “X-Rated Honey,” these male enhancement products have surged in...
For millions of people around the world, living with HIV no longer means an automatic decline in health. Antiretroviral therapy, commonly referred to as ART,...
For over a century, the discovery of insulin transformed Type 1 Diabetes (T1D) from a fatal diagnosis into a survivable condition. Yet, despite remarkable technological...
In recent years, post-traumatic stress disorder (PTSD) has increasingly come under the spotlight as one of the most complex and stubborn mental health conditions confronting...